S&P Futures
4,082.25 +2.25 (+0.06%) Dow Futures
33,042.00 -2.00 (-0.01%) Nasdaq Futures
13,089.50 +7.50 (+0.06%) Russell 2000 Futures
1,781.00 +0.90 (+0.05%) Crude Oil
74.15 -0.22 (-0.30%) Gold
1,994.40 -3.30 (-0.17%)
InVitro International (IVRO)
- Newsfile
IVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q1 2023 Results
Placentia, California--(Newsfile Corp. - February 8, 2023) - Today InVitro International (OTC Pink: IVRO), the 37 year pioneer developer and marketer of animal free testing methods, announced first fiscal quarter sales of $209,250, an increase of 14% over the same quarter last year. An operating loss of $31,169 was approximately 49% less than the prior years' first fiscal quarter operating loss and partially attributed to initial M&A activity. Our M&A activity has moved forward ...
- Newsfile
IVRO Continues to Help Make Non-Animal Testing Famous, Releases Fiscal 2022 Results
Placentia, California--(Newsfile Corp. - December 8, 2022) - InVitro International (OTC Pink: IVRO) today announced full year FY2022 sales results of $853,511 (-15%) and net income of $21,276 (-79%).CEO W. Richard Ulmer remarked: "We remain extremely enthusiastic regarding the future of NON-Animal testing despite somewhat disappointing, Covid related, FY '22 financial results. Our October '22 announcement of a Letter of Intent to merge with a well-established, privately owned laboratory adds gre
- Newsfile
IVRO Explores Opportunity for Growth
Placentia, California--(Newsfile Corp. - November 16, 2022) - InVitro International (OTC Pink: IVRO) today announced it has signed its first Letter of Intent (LOI) to acquire a privately owned, U.S. based testing laboratory. Over many years this laboratory has served IVRO targeted markets profitably and its principals agree that the future is bright for NON-Animal testing. CEO and Board Chairman, Rich Ulmer, opined, "Following our mission to Make NON-Animal Testing Famous, this initial acquisiti
